节点文献

冠状动脉介入手术对高血糖合并急性非ST段抬高型心肌梗死的治疗效果

Therapeutic Effect of Coronary Intervention on Hyperglycemia Complicated with Acute Non-ST Segment Elevation Myocardial Infarction

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李志张桂霞雷锐

【Author】 LI Zhi;ZHANG Guixia;LEI Rui;Jiamusi Central Hospital,Heilongjiang Province;

【通讯作者】 雷锐;

【机构】 黑龙江省佳木斯市中心医院

【摘要】 目的:探究冠状动脉介入手术对高血糖合并急性非ST段抬高型心肌梗死(NSTEMI)的治疗效果。方法:选取2020年1月-2022年1月佳木斯市中心医院收治的80例高血糖合并急性NSTEMI患者,按照随机数字表法分为研究组和对照组,各40例。对照组采用常规治疗,研究组则采用经桡动脉行冠状动脉介入(PCI)手术治疗,对比两组不良心血管事件发生率、心功能、血小板、血液因子水平等指标。结果:研究组治疗24 h后不良心血管事件发生率,以及治疗6 h后左心室排血时间(LVET)、心脏等容收缩时间(ICT)、血小板聚集率及黏附率、血糖水平与心肌型肌酸激酶同工酶(CK-MB)水平均低于对照组,差异均有统计学意义(P<0.05)。结论:冠状动脉介入手术能够有效缓解高血糖合并急性NSTEMI患者病症,减少治疗后不良心血管事件的发生,并改善患者的心功能,降低血小板的聚集率、黏附率,使血液因子水平尽量恢复正常,因此冠状动脉手术具有更好的治疗效果和安全性,具有推广价值。

【Abstract】 Objective: To explore the therapeutic effect of coronary intervention on hyperglycemia complicated with acute non-ST-segment elevation myocardial infarction(NSTEMI). Method: A total of 80 patients with hyperglycemia and acute NSTEMI treated in Jiamusi Central Hospital from January 2020 to January 2022 were randomly divided into study group and control group, with 40 cases in each group. The control group was treated with routine treatment and the study group was treated with percutaneous coronary intervention(PCI) through radial artery. The incidence of adverse cardiovascular events, cardiac function, platelet and blood factors levels were compared between the two groups. Result: After 24 h of treatment, the incidence of adverse cardiovascular events,and after 6 h of treatment, the left ventricular ejection time(LVET), cardiac isovolumic contraction time(ICT),platelet aggregation rate and adhesion rate, blood glucose level and myocardial isoenzyme(CK-MB) level in the study group were significantly lower than those in the control group(P<0.05). Conclusion: Coronary intervention can effectively alleviate the symptoms of patients with hyperglycemia complicated with acute NSTEMI, reduce the occurrence of adverse cardiovascular events after treatment, and improve the cardiac function of patients, reduce the aggregation rate, adhesion rate of platelets, make the blood factor level back to normal as far as possible, so coronary artery surgery has better treatment effect and safety, has promotion value.

  • 【文献出处】 中国医学创新 ,Medical Innovation of China , 编辑部邮箱 ,2022年36期
  • 【分类号】R542.22
  • 【下载频次】18
节点文献中: